Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe

Mithridion, Inc. Announces New Funding and Outlines Strategy for Central Nervous System Drug Development

January 11, 2011 By Bio-Medicine.Org

MADISON, Wis. and TOLEDO, Ohio, Jan. 11, 2011 /PRNewswire/ —
Mithridion, Inc., a privately-owned clinical stage drug development
company focusing on serious Central Nervous System disorders,
including Alzheimer’s disease, announces that it has secured
commitments of $1.25 million in new funding.  

Venture Investors (VI – Madison, Wis.), The State of
Wisconsin Investment Board (SWIB – Madison, Wis.), and Rocket
Venture Fund (Toledo, Ohio) participated in the latest funding.

“We plan to use this new funding to explore additional niche
disease targets for MCD-386CR, our lead clinical drug candidate,
which is a new strategy for the company, to seek partners for our
drug candidates MCD-386CR and MI-10-022 for Alzheimer’s disease
(AD)  and schizophrenia, and to augment our science advisory
board and board of directors,” said Trevor M. Twose, Ph.D., the
company’s Chief Executive. “We greatly appreciate the continued
confidence of our shareholders,” he added.

Mithridion intends to develop its drug candidates for AD and
schizophrenia in partnership with pharmaceutical or
biopharmaceutical companies with the technical, manufacturing and
commercial resources to address these major market opportunities.
 

As a new part of its strategy, Mithridion is actively exploring
opportunities to develop its drug candidates in niche market
opportunities in serious CNS disorders.  Several promising
disease targets have been identified and are currently being
evaluated.  The company believes that it will be able to
create additional high value and strong entry barriers through this
strategy, which it intends to fund using a combination of equity
capital and non-dilutive funding.

MCD-386CR, a clinical-stage drug candidate with an open IND, has
“first-in-class” potential for improving memory and cognition in
AD, for improving cognition in schizophrenia, and for
disease-modifying effects (or stopping disease progressio

‘/>”/>

SOURCE

Related Articles Read More >

Carnegie Mellon University EEG-based BCI to control robotic hand
Non-invasive BCI enables robotic hand dexterity
A photo of nitinol, a nickel-titanium alloy used for medical devices such as stents, heart valves, catheters and orthopedics.
What is nitinol and where is it used?
How this device broke through the blood-brain barrier
A photo of the miniature Auxilium Biotechnologies implants made on the International Space Station.
Implants 3D-printed in space could enable nerve regeneration
“mdo
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest medical device business news, application and technology trends.

DeviceTalks Weekly

See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to our E-Newsletter
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2025 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe